title: Prostaglandin E1 in the pretransplantation period in patients with pulmonary hypertension.
authors.forename: A
authors.initials: A
authors.lastname: Wasler
authors.forename: F
authors.initials: F
authors.lastname: Iberer
authors.forename: K H
authors.initials: KH
authors.lastname: Tscheliessnigg
authors.forename: T
authors.initials: T
authors.lastname: Auer
authors.forename: B
authors.initials: B
authors.lastname: Petutschnigg
mesh_terms: D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D002303:Cardiac Output, Low / Q000517:prevention & control; D004361:Drug Tolerance; D016027:Heart Transplantation; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000517:prevention & control; D011292:Premedication; D011652:Pulmonary Circulation / Q000187:drug effects / Q000502:physiology; D014655:Vascular Resistance / Q000187:drug effects / Q000502:physiology
chemical_list: D000527:Alprostadil